ROIV Roivant Sciences PE ratio, current and historical analysis
As of Dec 26, 2024, the Roivant Sciences stock's PE ratio is 2.02. This results from the current EPS of $5.95 and stock price of $12. The P/E ratio has an increase of 5% from the past four quarters average of 1.9.
ROIV PE ratio history
Roivant Sciences PE ratio by year
| Year | PE ratio | Change |
|---|---|---|
| 2024 | 1.9 | N/A |
| 2023 | N/A | N/A |
| 2022 | N/A | N/A |
| 2021 | N/A | N/A |
| 2020 | N/A | N/A |
ROIV average PE ratio chart
ROIV PE vs peers
ROIV's PE ratio is lower than its peer stock ORMP.
| Stock name | PE ratio | Market cap |
|---|---|---|
| ROIV Roivant Sciences Ltd | 1.99 | $8.6B |
| ORMP Oramed Pharmaceuticals Inc | 21.5 | $95.34M |
| OLMA Olema Pharmaceuticals Inc | N/A | $351.24M |
| OMER Omeros Corp | N/A | $640.92M |
| OMGA Omega Therapeutics Inc | N/A | $47.01M |
| ONVO Organovo Holdings Inc | N/A | $5.31M |
| ORIC Oric Pharmaceuticals Inc | N/A | $566.3M |
Frequently asked questions
What is Roivant Sciences's PE ratio?
ROIV's price to earnings ratio is 2.02 as of Dec 26, 2024.
Why is Roivant Sciences's PE ratio so low?
ROIV's PE ratio is low because its earnings per share (EPS) is high relative to its stock price.
How is ROIV's PE ratio calculated (Roivant Sciences PE ratio formula)?
To determine the PE ratio, divide the most recent stock price by the TTM earnings per share (EPS). As of today (Dec 26, 2024), Roivant Sciences's stock price is $12. The earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $5.95. Therefore, Roivant Sciences's P/E ratio for today is 2.02. PE RATIO(2.02) = STOCK PRICE($12) / TTM EPS($5.95)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.